Mar 31, 2015
1. Rights, Preferences and restrictions attached to Equity Shares
The Company has one class of Equity shares having at par value of Rs 10
per Share.Each Shareholder is eligible for one vote per Share held.
The dividend proposed by the Board of Directors is Subject to approval
of Shareholders in the ensuing Annual General Meeting. In the event of
liquidation of the company,the equity shareholders will be entitled to
receive remaining assets of the company, after distribution of all
Preferential amounts. The distribution will be in proportion to the
number of equity shares held by the shareholders.
2. Working capital Loan is taken from Export-Import Bank of India
@ 5.328% interest and the loan is secured by creating paripas sufirst
charge on the present & future current assets and corporate office
Building of the company. Second charge on present and future Fixed
assets. The loan is also secured by the personal. guarantee given by
Dr.Jayaram Chigurupati, Chairman of the Company.
3. In the opinion of the Management , the provision for diminution in
the value of investments relating to domestic and foreign subsidiaries
is due to permanent diminution in the value of investments.
4. The investment of preference shares in Hemarus Therapeutics
Limited is redeemable within 7 years from the date of allotment at
Rs.172/- and is based on a valuation report. In the opinion of the
management, the said investment is realisable at the value stated in
the balance sheet.
5. Contingent Liabilities
Particulars 31st March, 2015 31st March, 2014
i) Claims against the Company not
acknowledged as debt
APCPDCL wheeling charges claim in
Supreme Court 8,780,033 8,780,033
ii) Guarantees
Corporate Guarantees given on behalf
of Subsidiary Companies 15,805,489 15,805,489
6. Related Party Disclosures: As per AS-18
i) Subsidiary Companies:
Techtran Opthalmics Private Limited Techtran Lenses, Inc USA Techtran
LLC, USA Techtran Optics Private Limited
ii) Key Management Personnel
Sri. Devendra Patil - Chief Executive Officer - upto 31st July 2014 Sri
C.K.Hariharan - Manager from 25th March 2015
iii) Dr.Jayaram Chigurupati, Chairman
7. Certain balances of domestic and export debtors and creditors
are subject to confirmation and reconciliation.
8. Previous Year figures are regrouped/rearranged/reclassified
wherever necessary to conform to the current year classification.
Mar 31, 2014
1. Rights, Preferences and restrictions attached to Equity Shares
The Company has one class of Equity shares having at Par Value of Rs 10
per Share. Each Shareholder Is eligible for one vote per Share held.
The divident proposed by the Board of Directors Is Subject to approval
of Shareholders In the ensuing Annual General Meeting. In the event of
liquidation of the company, the equity shareholders will be entiled to
receive remaining assets of the company, after distribution of all
Preferential amounts. The distribution will be in proportion to the
number of equity shares hel by the shareholders.
2. Contingent Liabilities
(Amount in Rupees)
Particulars 31st March, 2014 31st March, 2013
i) Claims against the Company
not acknowledged as debt APCPDCL
wheeling charges claim in
Supreme Court 8,780,033 8,780,033
ii) Guarantees
Corporate Guarantees given on
behalf of Subsidiary Companies 15,805,489 12,500,000
3. Related Party Disclosures:
i) Key Management Personnel
Sri. E.Ranga Kumar - Whole Time Director - up to21.08.2013
Sri. Deven Patil - Chief Executive Officer - from 18.09.2013
ii) Subsidary Companies:
Techtran Opthalmics Private Limited
Techtran Lenses, Inc USA
Techtran LLC, USA
Techtran Optics Pvt. Ltd.
iii) Dr.Jayaram Chigurupati, Chairman
iv) Companies in which substantial interest by Directors
Hemarus Therapeutics Ltd
Credence Infrastructure Limited
4. Previous Year figures are regrouped/rearranged/reclassified wherever
necessary conform the current year
Mar 31, 2013
Note 1.1 Working capital Loan Is taken from EXIM bank @ 5.489 %
interest and the loan Is secured by creating pari passu first charge on
the present & future current assets of the company. The loan Is also
secured by the personal guarantee given by DrJayaram Chigurupati,
Chairman of the Company.
Note - 2.1: The Company has calculated provision for tax for the
current year and for the previous year without considering the
financials of Hemarus Therapeutics Limited as the merger application Is
pending before the Honourable High Court of Andhra Pradesh for
approval. The Provision for tax will be reworked as and when the
Hon''ble High Court of Andhra Pradesh gives the approval for Merger by
taking Into financials of Hemarus Therapeutics Limited.
Not* - 3: Segment Reporting:
The company is engaged In the manufacturing of Ophthalmic lenses. As
per Accounting Standard 17 Is considered this is the only reportable
business segment. As part of secondary reporting, revenues are
attributed to geographic areas based on the location of the customers
Note: - 4 Related Party Disclosures:
i) Associate Company:
Credence Infrastructure Limited H) Subsidary Companies:
Techtran Opthalmlcs Private Limited Techtran Optics Private Limited
Techtran Lenses, Inc USA Techtran LLC, USA Ri) Key Management Personnel
Sri. E.Ranga Kumar - Whole Time Director
Shri Dr Jayaram Chigurupati, Chairman
Note *5: Previous Year figures are regrouped/rearranged/redassifled
wherever nece&sary.
Mar 31, 2012
Note 1.1 The working capital is taken from EX!M bank @ 5.489 % interest
and the loan is secured by creating pari passu first charge on the
present & future current assets of the company, the loan is also
secured by the personal guarentee by the promoter director
Note 2.1 Out of the said amount Rs. NIL (Previous year Rs. 4,00,464)
pertains to Micro, Small and Medium enterprises as defined under Micro,
Small and Medium Enterprises Developmenent Act, 2006 based on the
information available with the company
Note: 3.1 - Salary Advances of Rs.20,72,000 (P.Y Rs.20,72,000)
represent the amount of dues from the erstwhile directors pending full
and final settlement
Note: 4.1 - Fixed deposits with maturity period of less than 3 months
& balances in unclaimed dividend accounts are considerd as cash
equivalents
Note: 4.2 - Fixed deposits with maturity period of more than 12 months
are Rs.50,000,000 (PY Rs. Nil)
Note - 5; Contingent Liabilities (Amount in Rupees)
Particulars 31st Mar 2012 31st Mar 2011
i) Claims against the Company not
acknowledged as debt
APCPDCL wheeling charges claim in
Supreme Court 8,780,033 8,780,033
ii) Guarantees
Corporate Guarantees given on behalf
of Subsidiary Company 12,500,000 12,500,000
Note - 6: Segment Reporting:
The company is engaged in manufacturing of Ophthalmic lenses business
which as per Accounting Standard 17 is considered the only reportable
business segment. As part of secondary reporting, revenues are
attributed to geographic areas based on the location of the customers
Note: - 7 Related Party Disclosures:
i) Associate Company:
Credence Infrastructure Limited
ii) Subsidary Companies:
Techtran Opthalmics Private Limited
Techtran Optics Private Limited
Techtran Lenses Inc USA
iii) Key Management Personnel
Sri. E.Ranga Kumar - Whole Time Director
Transactions were carried out with the related parties
The Company has made relevant disclosures which are applicable as per
revised Schedule VI and the figures for the previous year are
reclassified/regrouped and rearranged wherever necessary
Mar 31, 2011
2010-11 2009-10
1. Contingent liabilities:
Claims not acknowledged as debts:
a) APCPDCL wheeling charges claim 87,80,033 87,80,033
in Supreme Court
b) Corporate Guarantees given on behalf of
M/S Techtran Ophthalmics Private Limited 1,25,00,000 1,11,00,000
2. Working capital limits are secured by personal guarantees of two of
the directors of the company.
3. Loans and Advances include Rs.20,72,000/- Shown against the
erstwhile directors pending Full and final settlement of their
accounts.
4. Segment Reporting:
The company is engaged in manufacturing of Ophthalmic lenses business
which as per Accounting Standard 17 is considered the only reportable
business segment. As part of secondary reporting, revenues are
attributed to geographic areas based on the location of the customers.
5. Related Party Disclosures:
a) Relationship
i. Associate company: Credence Infrastructure Limited
ii. 100% Subsidiary Company: Techtran Ophthalmics Private Ltd
iii. Key Management Personnel Relatives
E. Ranga Kumar - Whole Time Director w.e.f. 15th March 2011
K. V. Rao (upto 15-03-2011) Leelavathi K Rao, Wife
Rob K. Rao, Son
Sajan K. Rao, Son
Neena K. Rao, Daughter
K. Krishnadev Rao (upto 06-01-2011) K. Vijayalakshmi, Wife
K. Amruta Devi, Mother
K. Srilatha Rao, Daughter
K. Krishnasree Rao, Daughter
K. Vishnudev Rao, Son
6. Previous year figures have been regrouped / recasted wherever
considered necessary to make them comparable with those of the current
year.
Mar 31, 2010
1. The term loans from financial institutions are secured by a first
charge on a pari passu basis on all the companys immovable and
movables including movable machinery, machinery spares, tools,
accessories present and future, except the companys stock of raw
materials, semi finished and finished goods, consumables stores, book
debts and such other movables on which the banks / institutions who
have sanctioned working capital limits have a first charge. Working
capital limits are secured by personal guarantees of two of the
directors of the company.
2. Unclaimed dividend of Rs 13,76,560 is included in other liabilities
under Current Liabilities and Provisions.
3.Segment Reporting:
The company is engaged in manufacturing of Ophthalmic lenses business
which as per Accounting Standard 17 is considered the only reportable
business segment. As part of secondary reporting, revenues are
attributed to geographic areas based on the location of the customers.
4. Related Party Disclosures:
a) Relationship
i. Subsidiary Company: Techtran Ophthalmics Private Limited
ii. Other Related Company: Techtran Agro Industries Limited
(Closed & defunct)
iii. Key Management Personnel Relatives
K. V. Rao Leelavathi K Rao, Wife
Rob K. Rao, Son
Sajan K. Rao, Son
Neena K. Rao, Daughter
K. Krishnadev Rao K. Vijayalakshmi, Wife
K. Amruta Devi, Mother
K. Srilatha Rao, Daughter
K. Krishnasree Rao, Daughter
K. Vishnudev Rao, Son
5. Previous year figures have been regrouped / recasted wherever
considered necessary to make them comparable with those of the current
year.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article